Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis von Rotstein, Dalia, Montalban, Xavier

Volltext

Multiple sclerosis: clinical aspects von Oh, Jiwon, Vidal-Jordana, Angela, Montalban, Xavier

Volltext

Body fluid biomarkers in multiple sclerosis von Comabella, Manuel, Dr, Montalban, Xavier, Prof

Volltext

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis von Montalban, Xavier, Arnold, Douglas L, Weber, Martin S, Staikov, Ivan, Piasecka-Stryczynska, Karolina, Willmer, Jonathan, Martin, Emily C, Dangond, Fernando, Syed, Sana, Wolinsky, Jerry S

Volltext

Ocrelizumab: a new milestone in multiple sclerosis therapy von Mulero, Patricia, Midaglia, Luciana, Montalban, Xavier

Volltext

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines von Filippi, Massimo, Prof, Rocca, Maria A, MD, Ciccarelli, Olga, Prof, De Stefano, Nicola, MD, Evangelou, Nikos, PhD, Kappos, Ludwig, Prof, Rovira, Alex, MD, Sastre-Garriga, Jaume, MD, Tintorè, Mar, MD, Frederiksen, Jette L, Prof, Gasperini, Claudio, MD, Palace, Jacqueline, MD, Reich, Daniel S, MD, Banwell, Brenda, Prof, Montalban, Xavier, Prof, Barkhof, Frederik, Prof

Volltext

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice von Sastre-Garriga, Jaume, Pareto, Deborah, Battaglini, Marco, Rocca, Maria A., Ciccarelli, Olga, Enzinger, Christian, Wuerfel, Jens, Sormani, Maria P., Barkhof, Frederik, Yousry, Tarek A., De Stefano, Nicola, Tintoré, Mar, Filippi, Massimo, Gasperini, Claudio, Kappos, Ludwig, Río, Jordi, Frederiksen, Jette, Palace, Jackie, Vrenken, Hugo, Montalban, Xavier, Rovira, Àlex

Volltext

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis von Hauser, Stephen L, Bar-Or, Amit, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Montalban, Xavier, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Wolinsky, Jerry S, Arnold, Douglas L, Klingelschmitt, Gaelle, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Chin, Peter, Mairon, Nicole, Garren, Hideki, Kappos, Ludwig

Volltext

Ofatumumab versus Teriflunomide in Multiple Sclerosis von Hauser, Stephen L, Bar-Or, Amit, Cohen, Jeffrey A, Comi, Giancarlo, Correale, Jorge, Coyle, Patricia K, Cross, Anne H, de Seze, Jerome, Leppert, David, Montalban, Xavier, Selmaj, Krzysztof, Wiendl, Heinz, Kerloeguen, Cecile, Willi, Roman, Li, Bingbing, Kakarieka, Algirdas, Tomic, Davorka, Goodyear, Alexandra, Pingili, Ratnakar, Häring, Dieter A, Ramanathan, Krishnan, Merschhemke, Martin, Kappos, Ludwig

Volltext

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis von Montalban, Xavier, Hauser, Stephen L, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S

Volltext

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria von Thompson, Alan J, Banwell, Brenda L, Barkhof, Frederik, Carroll, William M, Coetzee, Timothy, Comi, Giancarlo, Correale, Jorge, Fazekas, Franz, Filippi, Massimo, Freedman, Mark S, Fujihara, Kazuo, Galetta, Steven L, Hartung, Hans Peter, Kappos, Ludwig, Lublin, Fred D, Marrie, Ruth Ann, Miller, Aaron E, Miller, David H, Montalban, Xavier, Mowry, Ellen M, Sorensen, Per Soelberg, Tintoré, Mar, Traboulsee, Anthony L, Trojano, Maria, Uitdehaag, Bernard M J, Vukusic, Sandra, Waubant, Emmanuelle, Weinshenker, Brian G, Reingold, Stephen C, Cohen, Jeffrey A

Volltext

Biosensors to monitor MS activity von Graves, Jennifer S, Montalban, Xavier

Volltext

Keeping standards of multiple sclerosis care through the COVID-19 pandemic von Sastre-Garriga, Jaume, Tintoré, Mar, Montalban, Xavier

Volltext

Disease-modifying therapy in multiple sclerosis: Two guidelines (almost) passing in the night von Marrie, Ruth Ann, Montalban, Xavier

Volltext

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis von Montalban, Xavier, Gold, Ralf, Thompson, Alan J, Otero-Romero, Susana, Amato, Maria Pia, Chandraratna, Dhia, Clanet, Michel, Comi, Giancarlo, Derfuss, Tobias, Fazekas, Franz, Hartung, Hans Peter, Havrdova, Eva, Hemmer, Bernhard, Kappos, Ludwig, Liblau, Roland, Lubetzki, Catherine, Marcus, Elena, Miller, David H, Olsson, Tomas, Pilling, Steve, Selmaj, Krysztof, Siva, Aksel, Sorensen, Per Soelberg, Sormani, Maria Pia, Thalheim, Christoph, Wiendl, Heinz, Zipp, Frauke

Volltext

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis von Comi, Giancarlo, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Boyko, Alexey, Rocca, Maria A, Filippi, Massimo

Volltext

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies von Ruiz de Morales, José María G., Puig, Lluís, Daudén, Esteban, Cañete, Juan D., Pablos, José Luis, Martín, Antonio Olveira, Juanatey, Carlos González, Adán, Alfredo, Montalbán, Xavier, Borruel, Natalia, Ortí, Guillermo, Holgado-Martín, Esther, García-Vidal, Carolina, Vizcaya-Morales, Cynthia, Martín-Vázquez, Víctor, González-Gay, Miguel Ángel

Volltext

The Multiple Sclerosis Care Unit von Soelberg Sorensen, Per, Giovannoni, Gavin, Montalban, Xavier, Thalheim, Christoph, Zaratin, Paola, Comi, Giancarlo

Volltext

Therapeutic Inertia in the New Landscape of Multiple Sclerosis Care von Saposnik, Gustavo, Montalban, Xavier

Volltext

Treatment decisions in multiple sclerosis — insights from real-world observational studies von Trojano, Maria, Tintore, Mar, Montalban, Xavier, Hillert, Jan, Kalincik, Tomas, Iaffaldano, Pietro, Spelman, Tim, Sormani, Maria Pia, Butzkueven, Helmut

Volltext